Somar

Grupo Somar is a Mexico City-based private pharmaceutical company founded in 2011, operating with 501–1,000 employees and serving institutional and distributor buyers through a dedicated B2B portal.

Company typePrivate
Founded2011
HeadquartersMexico City, Mexico
Headcount501–1,000
GTM typeB2B
OfferingHardware or Manufacturing

What Somar does

Grupo Somar (legally Grupo Somar – Grupo Farmacéutico) is a privately held pharmaceutical company headquartered in Mexico City, founded in 2011 and operating with an employee base in the 501–1,000 range. Its corporate identity, channels, and business activity are anchored in the Mexican pharmaceutical sector, serving what appears to be an institutional and distributor customer base. The only public-facing product offering documented in available sources is a B2B portal (somar.portalhib2b.com), which the company uses to provide ordering or partner access for its pharmaceutical portfolio to business customers.

The company operates almost entirely off a single online touchpoint: its corporate website at gruposomar.com, which is currently in maintenance mode and routes visitors to its LinkedIn page and the B2B portal. Distribution is structured through a wholesale/distributor channel targeting enterprise buyers, with a linked whistleblower hotline (letica.mx/GrupoSomar) signaling standard corporate compliance infrastructure. No pricing, public product catalog, certifications, app presence, API, or integration ecosystem is publicly disclosed.

The business model is B2B pharmaceutical distribution, monetized through sales of pharmaceutical products to institutional buyers via the dedicated portal. Capital structure is opaque: a single $500,000 funding event is recorded in 2017 from investor Envelp, which is inconsistent with the company's stated headcount and may reflect limited public disclosure rather than true capital intensity. Leadership consists of CEO Daniel Del Conde and CFO Guillermo Perea Lopez, with no additional management team disclosed.

Somar firmographics

Firmographics

Name: Somar
Legal name: Grupo Somar
Website: https://gruposomar.com
Company type: Private
Founded year: 2011
Headcount range: 501–1,000 employees
Short description: Grupo Somar is a Mexico City-based private pharmaceutical company founded in 2011, operating with 501–1,000 employees and serving institutional and distributor buyers through a dedicated B2B portal.
Ownership category
akta.pro rank

Where Somar is headquartered

Location

Headquarters

HQ city: Mexico City
HQ country: Mexico
HQ region: Latin America

Markets served

Somar business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Supply Chain, Operations, Personnel, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Somar product offering

Product offering

Core offering

Somar is a Mexican pharmaceutical group (Grupo Somar – Grupo Farmacéutico) that manufactures and distributes pharmaceutical products. The only publicly named commercial offering is a B2B portal (somar.portalhib2b.com) that gives business buyers — distributors, wholesalers and institutional partners — access to its pharmaceutical portfolio. The corporate website is currently under maintenance and does not list the full product catalog.

Product overview

Somar (Grupo Somar – Grupo Farmacéutico) is a pharmaceutical group. The public website is currently under maintenance ("Sitio en mantenimiento") and does not describe the company's full product portfolio. The only named offering referenced on the page is a B2B portal (somar.portalhib2b.com), intended for business customers. No additional product modules, brands, or sub-products are documented in the available source material.

Differentiator

Problem solved

Functional benefit

Products and services

Grupo Somar B2B Portal Dedicated B2B portal accessible at somar.portalhib2b.com that gives business customers — pharmaceutical distributors, wholesalers and institutional buyers — access to Grupo Somar's pharmaceutical products. The portal's specific transaction functionality is not described on the corporate site.

Companies that use Somar

Customer profile

Ideal customer profiles1 record

Somar technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Somar partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

Somar competitors and assessment

Company assessment

Direct peers

Genomma Lab: One of Mexico's largest domestic pharmaceutical companies, focused on OTC and branded generics. Highly comparable to Somar as a Mexico-headquartered pharma group serving the same market and channels.
Productos Maver: Mexican pharmaceutical company offering generics and branded products across multiple therapeutic areas. Comparable to Somar as a domestic pharma group competing in similar retail and institutional channels.
Chinoin: Historic Mexican pharmaceutical manufacturer (part of P&G's prior pharma portfolio, now Aspen Pharmacare). Comparable to Somar as a domestic pharma group with a long Mexican operating history.
Laboratorios Liomont: Long-established Mexican pharmaceutical manufacturer with a broad branded-generic and OTC portfolio. Comparable to Somar as a domestic Mexican pharma group of similar size and market positioning.
PiSA Farmacéutica: One of Mexico's leading pharma manufacturers with hospital, retail, and institutional distribution. Comparable to Somar's institutional/B2B distribution orientation within the domestic Mexican market.
Laboratorios Sophia: Mexican pharmaceutical group with a strong specialty and institutional presence. Comparable to Somar as a Mexico-based pharma company with similar channel mix.

Regional players

Asofarma: Latin American-focused pharmaceutical company with significant presence across Mexico and other LATAM markets. Comparable as a regional pharma player with overlapping therapeutic and channel exposure.

Broad incumbents

Novartis Mexico: Multinational pharmaceutical company with established Mexico operations across innovative medicines and generics (Sandoz). Comparable as a broader incumbent competing in the same institutional and retail channels.
Bayer Mexico: Global life sciences company with a substantial Mexico pharmaceutical and consumer health presence. Comparable as a broader incumbent operating in overlapping OTC and prescription categories in Mexico.
Sanofi Mexico: Multinational pharmaceutical company with a major Mexico subsidiary spanning prescription, OTC, and vaccines. Comparable as a broader incumbent competing for the same institutional and retail channels in Mexico.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

Somar financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Somar leadership team

Management profile

Number of profiles

Profiles2 records

Somar funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Somar M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Somar

What does Somar do?

Is Somar a public or private company?

Somar is a private company. It is classified as unknown.

When was Somar founded?

Somar was founded in 2011. It employs 501 to 1,000 people.

Where is Somar based?

Somar is headquartered in Mexico City, Mexico, in the Latin America region.

Who are Somar's main competitors?

Direct peers on record are Genomma Lab, Productos Maver, Chinoin, Laboratorios Liomont, PiSA Farmacéutica and Laboratorios Sophia. Asofarma is listed as a regional player. Broad incumbents are Novartis Mexico, Bayer Mexico and Sanofi Mexico.

Does Somar have an API?

No public API is recorded for Somar.